A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)
Clinical trial NCT05557591 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05557591
- Sponsor
- Regeneron Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-21
- Primary completion
- 2028-01-26
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.